Published in Recenti Prog Med on June 01, 2002
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Oxidative stress in patients affected by primary aldosteronism. J Hypertens (2014) 3.34
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab (2008) 1.97
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
The functional HERG variant 897T is associated with Conn's adenoma. J Hypertens (2006) 1.41
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res (2010) 1.30
Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporos Int (2004) 1.21
Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev (2004) 1.16
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg (2010) 1.05
Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int (2004) 1.03
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab (2007) 1.02
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
High prevalence of epilepsy in a village in the Littoral Province of Cameroon. Epilepsy Res (2008) 0.95
Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab (2010) 0.95
Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center. Am Surg (2010) 0.93
Multiple catecholamine-secreting paragangliomas: diagnosis after hemorrhagic stroke in a young woman. Endocr Pract (2008) 0.92
The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol (2006) 0.90
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol (2007) 0.88
Thyroid cancer in patients with hyperthyroidism. Horm Res (2003) 0.87
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biother Radiopharm (2004) 0.86
von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma. Intern Med (2013) 0.85
Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma. Endocrine (2013) 0.85
Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol (2010) 0.84
Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) (2013) 0.83
KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens (2014) 0.83
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori (2005) 0.83
Adrenomedullin in perinatal medicine. Regul Pept (2003) 0.82
A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with vasculogenic erectile dysfunction. Int J Cardiol (2011) 0.81
Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol (2006) 0.81
Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J Clin Endocrinol Metab (2012) 0.81
Pigmented 'black' cardiac paraganglioma in a patient with a novel germ-line SDHD mutation. Eur J Cardiothorac Surg (2008) 0.80
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia. Metabolism (2007) 0.80
Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press Cardiovasc Prev (2013) 0.80
Role of growth factors on human parathyroid adenoma cell proliferation. World J Surg (2010) 0.80
Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol (2009) 0.80
Morphometric X-ray absorptiometry in the assessment of vertebral fractures in renal transplant patients. Nephrol Dial Transplant (2005) 0.80
Primary aldosteronism in a patient who exhibited heart failure. J Clin Hypertens (Greenwich) (2012) 0.79
Effects of prenatal betamethasone administration on leptin and adiponectin concentrations in maternal and fetal circulation. Am J Obstet Gynecol (2008) 0.79
Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension. Regul Pept (2008) 0.79
Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf) (2004) 0.78
Intrafollicular concentration of adrenomedullin is associated with IVF outcome. Gynecol Endocrinol (2010) 0.78
Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease). Arch Dermatol Res (2011) 0.78
Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism (2007) 0.78
Adrenomedullin in human male reproductive system. Eur J Obstet Gynecol Reprod Biol (2005) 0.78
Adrenomedullin and nitric oxide synthase at the maternal-decidual interface in early spontaneous abortion. J Reprod Med (2004) 0.78
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders. Intern Med (2013) 0.77
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. J Hypertens (2014) 0.77
A Case of Acute Aortic Dissection Type B Associated with Cushing's Syndrome. J Clin Med Res (2009) 0.77
Changes in the interrelationship between leptin, resistin and adiponectin in early neonatal life. Front Biosci (Elite Ed) (2010) 0.77
Follicular fluid adrenomedullin concentrations in spontaneous and stimulated cycles: relationship to ovarian function and endothelin-1 and nitric oxide. Regul Pept (2002) 0.77
Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem (2004) 0.77
Impact of fractures on health care in a major university hospital in Rome. Aging Clin Exp Res (2003) 0.76
High plasma adrenomedullin concentrations in patients with high-renin essential hypertension. J Renin Angiotensin Aldosterone Syst (2002) 0.76
Effect of betamethasone in vivo on placental adrenomedullin in human pregnancy. J Soc Gynecol Investig (2006) 0.76
[Clinical aspects of osteoporosis]. Recenti Prog Med (2002) 0.76
The level of adrenomedullin immunoreactivity in seminal fluid is higher in oligozoospermic subjects and correlates with semen biochemical parameters. Eur J Obstet Gynecol Reprod Biol (2006) 0.76
Ionised and total serum magnesium in renal transplant patients. J Nephrol (2002) 0.76
Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem (2007) 0.75
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan. Int J Cardiol (2012) 0.75
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. Medicine (Baltimore) (2016) 0.75
Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effort. Ann N Y Acad Sci (2006) 0.75
Adrenal Pheochromocytoma Incidentally Discovered in a Patient With Parkinsonism. Medicine (Baltimore) (2015) 0.75
Response to 'Oxidative stress in patients affected by primary aldosteronism'. J Hypertens (2015) 0.75
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics. Regul Pept (2006) 0.75
Effect of corticosteroids and progesterone on adrenomedullin output and expression in human fetal membranes and placenta trophoblasts. Am J Obstet Gynecol (2009) 0.75
In vitro effect of cyclosporine-A on angiotensins secretion by glomerular cells. Nephrology (Carlton) (2008) 0.75
Laparoscopic adrenal-sparing surgery: personal experience, review on technical aspects. Updates Surg (2011) 0.75
[The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover]. Ann Ital Med Int (2003) 0.75
Surgical treatment of extra-adrenal abdominal paragangliomas. Am Surg (2009) 0.75
Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens (Greenwich) (2006) 0.75
[Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia]. Ann Ital Med Int (2004) 0.75
An unusual association of cerebral meningioma, parathyroid adenoma and thyroid papillary carcinoma. Tumori (2006) 0.75
The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study. Calcif Tissue Int (2009) 0.75
P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids. Ann Diagn Pathol (2002) 0.75
[Secondary cardiovascular prevention after acute coronary syndrome in clinical practice]. G Ital Cardiol (Rome) (2010) 0.75
Atrogin-1 Pathway Activation in Cushing Syndrome Cardiomyopathy. J Am Coll Cardiol (2016) 0.75
Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease. JOP (2009) 0.75
Low-contrast medium doses for ultrasound imaging during renal revascularization by PTA-stenting. J Nephrol (2004) 0.75
[High prevalence of thyroid disfunction in primary hyperaldosteronism]. Recenti Prog Med (2005) 0.75
[Turnover of bone metabolism and prevalence of vertebral fractures in adrenal incidentalomas]. Recenti Prog Med (2004) 0.75
A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene. J Renin Angiotensin Aldosterone Syst (2004) 0.75
[Adrenal pheochromocytoma associated with "tako-tsubo" syndrome]. Recenti Prog Med (2011) 0.75
Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. J Hypertens (2019) 0.75